Longhua Hospital | Shanghai University of TCM | China
Author Profiles
Scopus
Orcid
Early Academic Pursuits
Qiong Wu began her academic journey in Traditional Chinese Medicine, completing her Bachelor’s degree in Acupuncture and Massage from Shanghai University of Traditional Chinese Medicine. She continued her education with a Master’s degree in Clinical Integrated Traditional Chinese and Western Medicine, further strengthening her expertise in bridging conventional and traditional medical practices. Her academic advancement culminated with a doctoral degree in Chinese Medicine, where she specialized in cardiovascular applications of integrated treatment approaches.
Professional Endeavors
Her professional trajectory has been closely linked with Longhua Hospital, affiliated to Shanghai University of Traditional Chinese Medicine. Beginning as a physician in multiple specialties including cardiology, neurology, respiratory medicine, nephrology, and endocrinology, she gained wide clinical exposure. Progressing into academic medicine, she served as an Assistant Professor in the Cardiovascular Department and is currently an Associate Professor in the same institution. These roles have allowed her to combine clinical service, academic teaching, and intensive research.
Contributions And Research Focus
Qiong Wu has accumulated nearly a decade of research experience centered on cardiovascular diseases such as dilated cardiomyopathy, ischemic heart disease, and hypertension. Her primary focus lies in pharmacological interventions, herb-drug interactions, and the integrated prevention of ventricular remodeling. She has developed specialized expertise in cardiomyocyte apoptosis, ventricular remodeling, and lymphatic vessel regeneration. She is proficient in advanced laboratory methodologies such as protein purification, RNA isolation, western blotting, immunohistochemistry, and cell culture, underscoring her capacity for translational cardiovascular research.
Impact And Influence
Her research has been recognized with competitive funding from prestigious sources, including the National Natural Science Foundation of China, the Shanghai Municipal Health Commission, and institutional programs at her university and affiliated hospital. These projects reflect both her leadership as a principal investigator and her commitment to bridging traditional medicine with modern biomedical science. Her contributions to clinical research include randomized, double-blind clinical studies on Traditional Chinese Medicine formulations for conditions such as atrial fibrillation and dilated cardiomyopathy.
Academic Cites
In addition to research articles, she has contributed significantly to scholarly literature through editorial roles. She has served as an associate editor for a comprehensive text on the integrated treatment of dilated cardiomyopathy and as a co-editor for a volume on chronic cor pulmonale. Her academic writings and publications not only disseminate knowledge but also serve as valuable references for the integration of traditional Chinese and Western medicine approaches in cardiovascular care.
Legacy And Future Contributions
Qiong Wu’s work exemplifies the convergence of clinical practice, experimental research, and traditional medicine innovation. Her patent applications on Chinese medicine compositions for atrial fibrillation and cardiomyopathy demonstrate her translational impact and potential for therapeutic innovation. As an active member of multiple professional committees within China, she is contributing to the shaping of national discourse on cardiovascular medicine, drug research, and clinical pharmacy in Traditional Chinese Medicine. Her legacy is likely to be defined by her role in validating and modernizing traditional formulations through rigorous clinical and experimental frameworks.
Conclusion
Qiong Wu stands out as an accomplished academician and researcher in the field of integrated cardiovascular medicine. With a strong foundation in both Traditional Chinese Medicine and modern biomedical approaches, she has advanced understanding in areas such as ventricular remodeling, herb-drug interactions, and clinical treatment of complex cardiovascular conditions. Her leadership in funded projects, editorial contributions, and patents positions her as an influential figure shaping the integration of traditional and contemporary practices. Looking forward, her ongoing research and clinical collaborations are expected to make lasting contributions to the global field of cardiovascular medicine.
Notable Publications
"Kuoxin Decoction Alleviated Left Ventricular Remodeling by Inhibiting Cardiomyocyte Apoptosis Through ASK1/JNK/Cx43 Signaling Pathway in cTnTR141W Transgenic Mice and in vitro"
Authors: Mengjiao Ma, Hua Fan, Yidan Dong, Tianyi Feng, Longping Peng, Maolin Zhou, Feifei Liu, RueyJyh Lee, Rongxue Wu, Qiong Wu et al.
Journal: Drug Design, Development and Therapy
Year: 2025
"Regulatory Effects of Zhenxin Formula in Treating Doxorubicin-Induced Heart Failure: Network Pharmacology and Animal Experimental Verification"
Authors: Qiong Wu, Hao Wang, You Wang, Jun Du, Bo Li, Xiao-Na Gan, Chen-Yang Liu, Jing Liang, Chang Liu, Min Cao
Journal: Drug Design, Development and Therapy
Year: 2025
"MMP3 at the Crossroads: Linking Molecular Pathways to Disease Diagnosis and Therapy"
Authors: Jing Jiang, Qiong Wu, Snekha Rajasekaran, Rongxue Wu
Journal: Pharmacological Research
Year: 2025
"Remote Ischaemic Pre-conditioning, Kidney Injury, and Outcomes After Coronary Angiography and Intervention: A Randomized Trial"
Authors: Ping Jia, Gang Zhao, Yuli Huang, Zhouping Zou, Qi Zeng, Weize Chen, Ting Ren, Yang Li, Xiaoyan Wang, Tingting Kang et al.
Journal: European Heart Journal
Year: 2025
"Astragalus Polysaccharide Protects Against Cardiac Injury in a tnnt2a Mutant Zebrafish Model of Dilated Cardiomyopathy"
Authors: Chang Zhou, Hui Zhao, Longping Peng, Yidan Dong, Qiong Wu, Xu Wang, Yingjia Xu, Youhua Wang
Journal: BMC Complementary Medicine and Therapies
Year: 2025
"Efficacy and Safety of Kuoxin Formula in the Treatment of Dilated Cardiomyopathy-Related Heart Failure: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial"
Authors: Qiong Wu, Shiying An, RueyJyh Lee, Dongwen Gao, Yinyifan Zhou, Longping Peng, Chunrui Hu, Lei Yao, Chang Zhou, Li Zhou et al.
Journal: International Journal of General Medicine
Year: 2024
"Comparison of Two Single-Pill Dual Combination Antihypertensive Therapies in Chinese Patients: A Randomized, Controlled Trial"
Authors: Qi-Fang Huang, Di Zhang, Yihong Luo, Kun Hu, Qiong Wu, Hailong Qiu, Fei Xu, Mei-Ling Wang, Xin Chen, Yan Li et al.
Journal: BMC Medicine
Year: 2024
"A Retrospective Study of Pupingqinghua Prescription Versus Lianhuaqingwen in Chinese Participants Infected With SARS-CoV-2 Omicron Variants"
Authors: Yidan Dong, Wei Zhai, Bangjiang Fang, Chenyang Liu, Suyun Yuan, Youhua Wang, Qixiang Song, Hai Li, Bin Chen, Dan Cui et al.
Journal: Frontiers in Pharmacology
Year: 2022